Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020115270 - BIOMARKER FOR DETECTING ZEARALENONE EFFECT

Publication Number WO/2020/115270
Publication Date 11.06.2020
International Application No. PCT/EP2019/083953
International Filing Date 06.12.2019
IPC
C12Q 1/6883 2018.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
68involving nucleic acids
6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
6883for diseases caused by alterations of genetic material
CPC
C12Q 1/6883
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
1Measuring or testing processes involving enzymes, nucleic acids or microorganisms
68involving nucleic acids
6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
6883for diseases caused by alterations of genetic material
C12Q 2600/158
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
2600Oligonucleotides characterized by their use
158Expression markers
C12Q 2600/178
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
2600Oligonucleotides characterized by their use
178miRNA, siRNA or ncRNA
Applicants
  • ERBER AKTIENGESELLSCHAFT [AT]/[AT]
Inventors
  • GRENIER, Bertrand
  • NAGL, Veronika
  • SCHATZMAYR, Gerd
  • BINDER, Eva-Maria
Agents
  • WEINZIERL, Gerhard
  • KOCH, Andreas Dr.
  • SCHIWECK, Wolfram Dr.
Priority Data
18210684.906.12.2018EP
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) BIOMARKER FOR DETECTING ZEARALENONE EFFECT
(FR) BIOMARQUEUR
Abstract
(EN)
The present invention relates to a novel method for detecting zearalenone (ZEN) effect comprising determining the expression level of at least one miRNA in a test sample, as well as to a novel use of at least one miRNA for detecting zearalenone (ZEN) effect in a test sample.
(FR)
La présente invention concerne un nouveau procédé de détection d'un Effet de zaralénone (ZEN) comprenant la détermination du niveau d'expression d'au moins un miARN dans un échantillon d'essai, ainsi qu'une nouvelle utilisation d'au moins un miARN pour détecter un effet de zaralénone (ZEN) dans un échantillon d'essai.
Also published as
Latest bibliographic data on file with the International Bureau